Differences in modulation of noradrenergic and serotonergic transmission by the Alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 852-860

  De Boer, T H ^a   Nefkens, F ^a   Van Helvoirt, A ^a   Van Delft, A M L ^a  

^a NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CREATININE; IDAZOXAN; MIANSERIN; MIRTAZAPINE; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCUS CERULEUS; MICRODIALYSIS; NONHUMAN; NORADRENERGIC SYSTEM; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; SEROTONINERGIC TRANSMISSION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CORPUS STRIATUM; DIOXANES; HIPPOCAMPUS; IDAZOXAN; IMIDAZOLES; MALE; MIANSERIN; NOREPINEPHRINE; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN; TETRODOTOXIN;

EID: 0030430274     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. AGHAJANIAN, G. K., SPROUSE, J. S. AND RASMUSSEN, K.: Physiology of midbrain serotonin systems. In Psychopharmacology: The Third Generation of Progress, ed. by H. Y. Meltzer, pp. 141-149, Raven Press, New York, 1987.
2. BARABAN, J. M. AND AGHAJANIAN, G. K.: Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19: 355-363, 1980.
3. BARABAN J. M. AND AGHAJANIAN, G. K.: Noradrenergic innervation of serotonergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography. Brain Res. 204: 1-11, 1981.
4. 3H]5-HT release after noradrenergic denervation with dsp4. Eur. J. Pharmacol. 119: 131-133, 1985.
5. 1 receptor agonists and p-chloroamphetamine. Synapse 5: 120-133, 1990.
6. CLEMENT, H.-H., GEMSA, D. AND WESEMANN, W.: The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetry. Eur. J. Pharmacol. 217: 43-48, 1992.
7. DE BOER, TH., MAURA, G., RAITERI, M., DE VOS, C. J., WIERINGA, J. AND PINDER, R. M.: Neurochemical and autonomic pharmacological profiles op the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology 27: 399-408, 1988.
8. 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur. J. Pharmacol. 253: R5-R6, 1994.
9. DENNIS, T., HEUREUX, R. L., CARTER, C. AND SCATTON, B.: Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis). J. Pharmacol. Exp. Ther. 241: 642-649, 1987.
10. 2-adrenoceptors, Br. J. Pharmacol. 78: 489-505, 1983.
11. FEUERSTEIN, T. J., HERTTING, G. AND JACKISCH, R.: Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT) release. Dual effects of yohimbine, rauwolscine and corynanthine as α-adrenoceptor antagonists and 5-HT receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 329: 216-221, 1985.
12. 3H-5-hydroxytryptamine release from rat hippocampus. Eur. J. Pharmacol 81: 97-106, 1982.
13. GARRATT, J. C., CRESPI, F., MASON, R. AND MARSDEN, C. A.: Effects of idazoxan on dorsal raphé 5-hydroxytryptamine neuronal function. Eur. J. Pharmacol. 193: 87-93, 1991.
14. GONON, F., BUDA, M., DE SIMONI, G. AND PUJOL, J.-F.: Catecholamine metabolism in the rat locus ceruleus as studied by in vivo differential pulse voltammetry. II. Pharmacological and behavioural study. Brain Res. 273: 207-216, 1983.
15. GÖTHERT, M., HUTH, H. AND SCHLICKER, E.: Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 317: 199-203, 1981.
16. GOWER, A. J., BROEKKAMP, C. L. E., RIJK, H. W. AND VAN DELFT, A. M. L.: Pharmacological evaluation of in vivo tests for α2-adrenoceptor blockade in the central nervous system and the effects of the enantiomers of mianserin and its aza-analogue Org 3770. Arch. Int. Pharmacodyn. Ther. 291: 185-201, 1988.
17. 2-adrenoceptor antagonist Org 3770 on rat 5-HT neurotransmission. Soc. Neurosci. Abstr. 20: 1553, 1994.
18. HADDJERI, N., BLIER, P. AND DE MONTIGNY, C.: Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J. Pharmacol. Exp. Ther. 277: 861-871, 1996.
19. ITOH, Y., OISHI, R , NISHIBORI, M. AND SAEKI, K.: In vivo measurement of noradreneline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: Effects of various drugs affecting noradrenaline metabolism. J. Pharmacol. Exp. Ther. 255: 1090-1097, 1990.
20. 3 receptors in cultured mouse neuroblastoma cells. Neuropharmacology 33: 501-510, 1994.
21. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol Exp. Ther 269: 1268-1279, 1994.
22. 2-adrenoceptors at the serotonergic axons of rabbit brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 332: 324-331, 1986.
23. 2-adrenoceptors located on serotonergic nerve terminals. Naunyn-Schmiedeberg's Arch. Pharmacol. 320: 272-274, 1982.
24. 2-adrenergic heteroreceptors of 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's. Arch. Pharmacol. 347: 266-272, 1993.
25. 2-adrenoreceptors on serotonin terminals following long-term treatment with drugs increasing NE synaptic concentration. Neuropsychopharmacology 10: 41-51, 1994.
26. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, London, 1982.
27. PESSIA, M., JIANG, Z. G., NORTH, R. A. AND JOHNSON, S. W.: Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654: 324-330, 1994.
28. PREZIOSI, P., MARTIRE, M., NAVARRA, P., PISTRITTO, G. AND VACA, M.: Prolactin-lowering ability of (±)-idazoxan may be linked to a central noradrenergic-serotonergic interplay. J. Pharmacol. Exp. Ther. 249: 256-263, 1989.
29. QUINTIN, L., HILAIRE, G. AND PUJOL, J. F.: Variations in 3,4-dihydroxyphenylacetic acid concentrations are correlated to single cell firing changes in the rat locus ceruleus. Neuroscience 18: 889-899, 1986.
30. RAITERI, M., MAURA, G. AND VERSACE, P.: Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release. J. Pharmacol. Exp. Ther. 153: 679-684, 1983.
31. 1-Adrenoceptor antagonists differentially control release in the hippocampus and striatum: A microdialysis study. Eur. J. Pharmacol. 261: 59-64, 1994.
32. RUIGT, G. S. F., ENGELEN, S., GERRITS, A. AND VERBON, F.: Computer based prediction of psychotropic drug classes based on a discriminant analysis of drug effects on rat sleep. Neuropsychobiology 28: 138-153, 1993.
33. SANTIAGO, M. AND WESTERINK, B. H. C.: Characterisation of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn-Schmiedeberg's Arch. Pharmacol. 342: 407-414, 1990.
34. 1B agonists. Synapse 1: 3-9, 1987.
35. 2-adrenergic agonist clonidine. Brain Res. 92: 291-306, 1975.
36. 2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:137-143, 1992.
37. THOMAS, D. N. AND HOLMAN, R. M.: Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br. J. Pharmacol. 106: 430-434, 1991.
38. VAHABZADEH, A. AND FILLENZ, M.: Studies on the origin of rat hippocampal dihydroxyphenylacetic acid using microdialysis. Neurosci. Lett. 136: 51-55, 1992.
39. 2-adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. Ther. 297: 190-204, 1989.
40. 2-Adrenoceptor modulation of 5-HT biosynthesis in the rat brain. Neurosci. Lett. 139: 53-56, 1992a.
41. YOSHIOKA, M., MATSUMOTO, M., TOGASHI, H., SMITH, C. B. AND SAITO, H.: Effect of clonidine on the release of serotonin from rat hippocampus as measured by microdialysis. Neurosci. Lett. 139: 57-60, 1992b.